Markets:

Overview

News

Currencies

International

Treasuries

Invivyd, Inc. - Common Stock (NQ:IVVD)

1.790 -0.050 (-2.72%)

Streaming Delayed Price Updated: 10:14 AM EST, Feb 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Invivyd, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Invivyd Announces Changes to Executive Team

February 03, 2023

From Invivyd

Via GlobeNewswire

INVIVYD ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Invivyd, Inc. and Encourages Investors to Contact the Firm

February 02, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) on Behalf of Investors

February 02, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

Bronstein, Gewirtz & Grossman, LLC Notifies Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) Investors of Class Action and to Actively Participate

February 02, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

NATIONALLY RANKED ROSEN LAW FIRM Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI

February 02, 2023

From Rosen Law Firm

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) on Behalf of Investors

February 01, 2023

From Law Offices of Howard G. Smith

Via Business Wire

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Invivyd, Inc. (IVVD) f/k/a Adagio Therapeutics, Inc.

February 01, 2023

From Robbins LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) on Behalf of Investors

February 01, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

February 01, 2023

From The Schall Law Firm

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

January 31, 2023

From The Schall Law Firm

Via Business Wire

IVVD INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case

January 31, 2023

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 23, 2023

Via Benzinga

Invivyd Presented Joint Industry Rationale on Potential Expedited Development Pathways for Monoclonal Antibodies at FDA-EMA Workshop

December 19, 2022

From Invivyd

Via GlobeNewswire

Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical Officer

December 06, 2022

From Invivyd

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 21, 2022

Via Benzinga

Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday ↗

November 22, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical Development in Infectious Diseases Including COVID-19

November 17, 2022

From Invivyd

Via GlobeNewswire

NASDAQ:IVVD Investor Alert: Investigation over Potential Wrongdoing at Invivyd, Inc. ↗

November 11, 2022

San Diego, CA -- (SBWIRE) -- 11/11/2022 -- Certain directors of Invivyd, Inc. are under investigation over potential breaches of fiduciary duties.

Via SBWire

Invivyd Reports Third Quarter 2022 Financial Results and Business Highlights

November 10, 2022

From Invivyd

Via GlobeNewswire

Invivyd to Participate in Fireside Chat at the Jefferies London Healthcare Conference

November 09, 2022

From Invivyd

Via GlobeNewswire

Invivyd Announces the Appointment of Christine Lindenboom to Board of Directors

October 24, 2022

From Invivyd

Via GlobeNewswire

Why Snap Shares Are Trading Sharply Lower; Here Are 25 Stocks Moving Premarket ↗

October 21, 2022

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 40.9% to $0.2160 in pre-market trading. Statera Biopharma recently signed a binding Memorandum of Understanding with Holobeam Technologies Inc.

Via Benzinga

Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday ↗

October 21, 2022

Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million...

Via Benzinga

Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session ↗

October 20, 2022

Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment.

Via Benzinga

AT&T, IBM, Las Vegas Sands And Some Other Big Stocks Moving Higher On Thursday ↗

October 20, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Invivyd, Inc. (NASDAQ:IVVD) Shareholder Notice: Investigation over Possible Violations of Securities Laws ↗

October 17, 2022

San Diego, CA -- (SBWIRE) -- 10/17/2022 -- Invivyd, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

US Stock Futures Edge Lower Following Thursday's Rally; Big Bank Earnings In Focus ↗

October 14, 2022

Pre-open movers

Via Benzinga

Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer and Announces Resource Reallocation to Maximize Integrated Discovery Platform

October 13, 2022

From Invivyd

Via GlobeNewswire

Invivyd to Present Multiple Posters Highlighting Clinical Data from Adintrevimab During ID Week 2022

October 12, 2022

From Invivyd

Via GlobeNewswire

In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews David Hering CEO, Invivyd Inc.

October 03, 2022

Via ACCESSWIRE

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.